Psoriatic Arthritis Treatment Market Report and Forecast 2025-2034

The psoriatic arthritis treatment market value was USD 13.38 Billion in 2024, driven by the prevalence of psoriatic arthritis across the globe. The market size is anticipated to grow at a CAGR of 9.80% during the forecast period of 2025-2034 to achieve a value of USD 34.08 Billion by 2034.

It is estimated that psoriasis affects more than 125 million individuals around the globe, and psoriasis tends to create psoriatic arthritis in 30% of the population. The global industry for psoriatic arthritis treatment is influenced by an increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis.

Market Segmentation

Psoriatic arthritis is a chronic psoriasis-related degenerative disorder. Swollen fingers, toes, and tender joints, stiffness, lowered back pain, and pitted nails are prevalent symptoms of psoriatic arthritis. Psoriatic arthritis treatment market can be divided on the basis of segments like drug class, product type and administration route.

Market Breakup by Drug Class

• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Disease-Modifying Antirheumatic Drugs (DMARDs)
• Immunosuppressants
• Biological Agents
• Corticosteroids
• Others

Market Breakup by Route of Administration

• Oral
• Parenteral
• Topical

Market Breakup by Drug Type

• Prescription
• Over The Counter

Market Breakup by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Market Analysis

The intensive research taking place to provide treatment to the patients suffering from psoriasis condition is driving the global psoriatic arthritis treatment industry. The other factors aiding in the growth of the industry are investments by major companies in clinical R&D, new product launches, increasing disease prevalence and proactive government initiatives. The factors such as high cost of treatment, stringent regulatory approval and adverse effect of drugs may hinder the growth of the market in coming future.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global psoriatic arthritis treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• AbbVie Inc.
• Janssen Global Services, LLC (Johnson & Johnson)
• Novartis AG
• Amgen Inc.
• Biogen Inc.
• Pfizer Inc.
• Eli Lilly and Company
• UCB S.A.
• Bristol-Myers Squibb Company
• Merck & Co. Inc.
• Others

The report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter's five forces.

Key Highlights of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

• Drug Class
• Route of Administration
• Drug Type
• Distribution Channel
• Region
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Disease-Modifying Antirheumatic Drugs (DMARDs)
• Immunosuppressants
• Biological Agents
• Corticosteroids
• Others
• Oral
• Parenteral
• Topical
• Prescription
• Over The Counter
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• Market Drivers and Constraints
• SWOT Analysis
• Porter's Five Forces Model
• Key Demand Indicators
• Key Price Indicators
• Industry Events, Initiatives, and Trends
• Value Chain Analysis
• Market Structure
• Company Profiles
• Financial Analysis
• Product Portfolio
• Demographic Reach and Achievements
• Mergers and Acquisitions
• Certifications
• AbbVie Inc.
• Janssen Global Services, LLC (Johnson & Johnson)
• Novartis AG
• Amgen Inc.
• Biogen Inc.
• Pfizer Inc.
• Eli Lilly and Company
• UCB S.A.
• Bristol-Myers Squibb Company
• Merck & Co. Inc.
• Others

This product will be delivered within 3-5 business days.